Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Charlesbank Capital Partners, while Ballard Spahr advised Boathouse Capital in the transaction. IMPLAN Group LLC (“IMPLAN” or the...
You must be a Standard 1 Year member to access this content.
Ballard Spahr assisted RhythMedix on the sale. Pharos Capital Group has acquired a majority stake in New Jersey-based RythMedix, a manufacturer and provider of remote cardiac...
You must be a Standard 1 Year member to access this content.
Ballard Spahr assisted 3Helix on the round. BASF and 3Helix Inc., a U.S.-based technology start-up, announced their innovation partnership on 3Helix’s proprietary CHP technology. The partnership...
You must be a Standard 1 Year member to access this content.
Ballard Spahr served as counsel to Boathouse Capital on the deal. Boathouse Capital announced its growth investment in Stravos Education LLC, an educational holding company with...
You must be a Standard 1 Year member to access this content.
Ballard Spahr advised FrontierView on the deal. Washington, D.C.-based FrontierView announced its recent acquisition by FiscalNote, a leading technology provider of global policy and marketing intelligence. FrontierView...
You must be a Standard 1 Year member to access this content.
Ballard Spahr advised PA Natural Medicine LLC on the deal. Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF), a vertically-integrated cannabis multi-state operator (MSO), has closed, through a...
You must be a Standard 1 Year member to access this content.
